Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,257,084 papers from all fields of science
Search
Sign In
Create Free Account
CDISC Questionnaire MPAI-4 Test Name Terminology
Known as:
MPAI1TN
, Mayo-Portland Adaptability Inventory-4 Questionnaire Test Name
, QS-MPAI-4 TEST
Test names of questionnaire questions associated with the Mayo-Portland Adaptability Inventory-4 (MPAI-4) for the Clinical Data Interchange Standards…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Clinical Data Interchange Standards Consortium Terminology
MPAI-4 - Abilities: Visuospatial Abilities
MPAI-4 - Law Violations Post-Injury
MPAI-4 - Law Violations Pre-Injury
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Preliminary investigation of the reliability and validity of the BIRT Independent Living Scale
S. Ramos
,
M. Oddy
,
Lorraine Haye
,
A. Goodson
Disability and Rehabilitation
2018
Corpus ID: 24272654
Abstract Purpose: Neurorehabilitation aims to increase independence and participation in ordinary life. It is argued that the…
Expand
2013
2013
Utility of the Mayo-Portland adaptability inventory-4 for self-reported outcomes in a military sample with traumatic brain injury.
J. Kean
,
J. Malec
,
D. Cooper
,
Amy O. Bowles
Archives of Physical Medicine and Rehabilitation
2013
Corpus ID: 11119711
2009
2009
The Italian version of the Mayo-Portland Adaptability Inventory-4. A new measure of brain injury outcome.
R. Cattelani
,
D. Corsini
,
L. Posteraro
,
M. Agosti
,
M. Saccavini
European Journal of Physical and Rehabilitation…
2009
Corpus ID: 24342390
AIM The assessment of major obstacles to community integration which may result from an acquired brain injury (ABI) is needed for…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE